The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia

被引:35
作者
Florio, P
Reis, FM
Pezzani, I
Luisi, S
Severi, FM
Petraglia, F
机构
[1] Univ Siena, Chair Obstet & Gynecol, Policlin Le Scotte, I-53100 Siena, Italy
[2] Univ Fed Minas Gerais, Dept Obstet & Gynecol, Belo Horizonte, MG, Brazil
[3] Univ Udine, Dept Surg Sci, Chair Obstet & Gynecol, I-33100 Udine, Italy
关键词
activin; Doppler; inhibin; predictive value; pre-eclampsia;
D O I
10.1002/uog.29
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Objective To evaluate whether the measurement of maternal serum activin A and inhibin A adds any clinically relevant information for the prediction of pre-eclampsia in women with altered uterine artery Doppler velocimetry at 24 weeks of gestation. Methods This was a prospective, controlled, hospital-based study involving 58 asymptomatic pregnant women at 24 weeks' gestation in whom a diastolic notch of the uterine artery waveform was noted at routine Doppler examination. Doppler assessment of the uterine artery waveform and measurement of maternal activin A and inhibin A serum levels by specific two-site enzyme immunoassays were performed. The cut-off points for defining 'high' serum activin A and inhibin A levels for prediction of pre-eclampsia were chosen by receiver-operating characteristics (ROC) curve analysis. The probability of developing pre-eclampsia was calculated for several combinations of results of hormone testing. Results Activin A and inhibin A levels were higher in patients who developed pre-eclampsia (n = 18; mean standard error: 2.69 +/- 0.35 ng/mL and 131.2 +/- 22.7 pg/mL, respectively) than in those who did not present with pre-eclampsia at follow-up (n 40; activin A: 1.79 +/- 0.18 ng/mL and inhibin A: 91.9 +/- 6.2 pg/mL; P < 0.05). Activin A at the cut-off value of 1.7 multiples of the median (MoM) achieved a sensitivity of 61% and a specificity of 89%, whereas inhibin A at the cut-off value of 1.8 MoM combined a sensitivity of 39% with a specificity of 92% for prediction of pre-eclampsia. The probability of pre-eclampsia was 31% in the whole study population, 86% if both activin A and inhibin A were elevated and 17% if both hormone markers were unaltered. Conclusion The measurement of serum activin A and inhibin A levels may add significant prognostic information for predicting pre-eclampsia in pregnant women showing specific Doppler alterations in the late second trimester. Copyright (C) 2003 ISUOG. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:165 / 169
页数:5
相关论文
共 21 条
[1]   One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation [J].
Albaiges, G ;
Missfelder-Lobos, H ;
Lees, C ;
Parra, M ;
Nicolaides, KH .
OBSTETRICS AND GYNECOLOGY, 2000, 96 (04) :559-564
[2]   Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia [J].
Aquilina, J ;
Barnett, A ;
Thompson, O ;
Harrington, K .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 181 (01) :131-136
[3]   Improved early prediction of pre-eclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler [J].
Aquilina, J ;
Thompson, O ;
Thilaganathan, B ;
Harrington, K .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 17 (06) :477-484
[4]  
CAMPBELL S, 1986, OBSTET GYNECOL, V68, P649
[5]   How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview [J].
Chien, PFW ;
Arnott, N ;
Gordon, A ;
Owen, P ;
Khan, KS .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2000, 107 (02) :196-208
[6]   Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders [J].
D'Antona, D ;
Reis, FM ;
Benedetto, C ;
Evans, LW ;
Groome, NP ;
de Kretser, DM ;
Wallace, EM ;
Petraglia, F .
JOURNAL OF ENDOCRINOLOGY, 2000, 165 (01) :157-162
[7]   Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy [J].
Gifford, RW ;
August, PA ;
Cunningham, G ;
Green, LA ;
Lindheimer, MD ;
McNellis, D ;
Roberts, JM ;
Sibai, BM ;
Taler, SJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (01) :S1-S22
[8]   Serum levels of activin A and inhibin A and the subsequent development of preeclampsia [J].
Grobman, WA ;
Wang, EY .
OBSTETRICS AND GYNECOLOGY, 2000, 96 (03) :390-394
[9]   DETECTION OF DIMERIC INHIBIN THROUGHOUT THE HUMAN MENSTRUAL-CYCLE BY 2-SITE ENZYME-IMMUNOASSAY [J].
GROOME, NP ;
ILLINGWORTH, PJ ;
OBRIEN, M ;
COOKE, I ;
GANESAN, TS ;
BAIRD, DT ;
MCNEILLY, AS .
CLINICAL ENDOCRINOLOGY, 1994, 40 (06) :717-723
[10]   Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid [J].
Knight, PG ;
Muttukrishna, S ;
Groome, NP .
JOURNAL OF ENDOCRINOLOGY, 1996, 148 (02) :267-279